Jaleh Fallah
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Prostate Cancer Treatment and Research 6
- Renal cell carcinoma treatment 5
- Oncology 9
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Brian I. Rini (4 shared papers)Adam J. Olszewski (6 shared papers)Jorge J. Castillo (2 shared papers)Daniel L. Suzman (10 shared papers)Richard Pazdur (9 shared papers)Laleh Amiri‐Kordestani (9 shared papers)Sundeep Agrawal (7 shared papers)Paul G. Kluetz (8 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Clinical Cancer Research (2 papers)Neuro-Oncology (2 papers)Blood (2 papers)Cancer (1 paper)
- Partner nations
- United StatesIndiaIran
In The Last Decade
Jaleh Fallah
23 papers receiving 596 citations
Jaleh Fallah's Hit Papers
Peers
Comparison fields: 5 of 74
- Cancer Research 224
- Oncology 211
- Pulmonary and Respiratory Medicine 204
- Genetics 58
- Pathology and Forensic Medicine 75
Countries citing papers authored by Jaleh Fallah
This map shows the geographic impact of Jaleh Fallah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaleh Fallah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaleh Fallah more than expected).
Fields of papers citing papers by Jaleh Fallah
This network shows the impact of papers produced by Jaleh Fallah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaleh Fallah. The network helps show where Jaleh Fallah may publish in the future.
Co-authors
The 25 scholars most cited alongside Jaleh Fallah, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 241 | |
| 2 | FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2022 | 127 |
| 3 | 2016 | 38 | |
| 4 | 2020 | 34 | |
| 5 | 2024 | 33 | |
| 6 | 2019 | 23 | |
| 7 | 2016 | 23 | |
| 8 | Type D personality and quality of life in patients with irritable bowel syndrome. | 2011 | 17 |
| 9 | 2020 | 14 | |
| 10 | 2024 | 9 | |
| 11 | 2020 | 8 | |
| 12 | 2023 | 8 | |
| 13 | 2020 | 5 | |
| 14 | 2024 | 4 | |
| 15 | 2024 | 4 | |
| 16 | 2019 | 4 | |
| 17 | 2021 | 3 | |
| 18 | 2019 | 2 | |
| 19 | 2015 | 2 | |
| 20 | 2024 | 1 |
About Jaleh Fallah
Jaleh Fallah is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Genetics and Pathology and Forensic Medicine, having authored 26 papers that have together received 603 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Prostate Cancer Treatment and Research (6 papers), Renal cell carcinoma treatment (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Cancer Research and Treatments (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Glioma Diagnosis and Treatment (3 papers) and Economic and Financial Impacts of Cancer (2 papers). The work is most often cited by research in Cancer Research (224 citations), Oncology (211 citations), Pulmonary and Respiratory Medicine (204 citations), Genetics (58 citations) and Pathology and Forensic Medicine (75 citations). Jaleh Fallah has collaborated with scholars based in United States, India and Iran. Frequent co-authors include Brian I. Rini, Adam J. Olszewski, Jorge J. Castillo, Daniel L. Suzman, Richard Pazdur, Laleh Amiri‐Kordestani, Sundeep Agrawal, Paul G. Kluetz, Shenghui Tang and Janice P. Dutcher. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Neuro-Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.